HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beauty.com/Bluefly.com

This article was originally published in The Rose Sheet

Executive Summary

Alliance of Beauty.com - "one of the fastest growing prestige beauty e-commerce sites" - and online designer clothing retailer Bluefly.com will provide " an all-encompassing prestige beauty and fashion experience" as the two seek to "intrigue" consumers with behind-the-scene trend videos and special promotions, according to Oct. 10 release. "Fashion and beauty have always been closely linked but rarely co-merchandised - especially online," Bluefly.com Chief Marketing Officer Bradford Matson notes. VP-Beauty for Beauty.com Kathleen McNeill states: "Beauty is an integral part of the fashion world, and the right choice of color cosmetics and hair will enhance any style of clothing." Consumers now can "get the perfect dress to wear with that new shade of red lipstick," she says, stressing the convenience of being able to assemble "head-to-toe looks with a few quick clicks." Currently viewable at the two sites is an inside look at a Bluefly photo shoot, as well as expert hair-styling instruction and makeup application tips...

You may also be interested in...



Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

 

 

Pipeline Watch: Phase III Readouts For Surufatinib, Tislelizumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Compliance Corner: The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm (Part 10)

A panel of longtime industry experts offer manufacturers a list of things they should and shouldn’t do when an investigator from the US agency knocks on their facility door. In this tenth and final installment of a 10-part series, the experts explain why it’s important to be honest with investigators at all times.

UsernamePublicRestriction

Register

RS015038

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel